BSQDQ - NITROSTAT IV,5 MG/ML

Product Identification

Product ID:NITROSTAT IV,5 MG/ML
MSDS Date:06/11/1991
FSC:6505
NIIN:01-204-3782
MSDS Number: BSQDQ

Responsible Party
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
201 TABOR RD
MORRIS PLAINS, NJ 07950-2614
US

Emergency Phone: 201-540-2000

Info Phone: 201-540-2000

Preparer: ROY MUELLER

Cage: 82559

Contractor
WARNER-LAMBERT CO
MORRIS PLAINS, NJ 07950-2614 US

Telephone: 201-540-2000

Cage: 82559

Ingredients

NITROGLYCERINE, NITRIN, NITROL

CAS: 55-63-0

RTECS: QX2100000

OSHA PEL 2 MG/CUM (SKIN)

ACGIH TLV: 0.46 MG/CUM

EPA Report Quantity: 10 LBS

DOT Report Quantity: 10 LBS


ETHANOL (ETHYL ALCOHOL), TECSOL, ALCOHOL

CAS: 64-17-5

RTECS: KQ6300000

Fraction By Weight: 30-60%

OSHA PEL 1000 PPM

ACGIH TLV: 1000 PPM


1,2-PROPANEDIOL (PROPYLENE GLYCOL)

CAS: 57-55-6

RTECS: TY2000000

Hazards

LD50 LC50 Mixture:ORAL LD50 (RAT): 7.06 G/KG ETHYL ALCOHOL
Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:HIGH CONCENTRATIONS OF NITROGLYCERIN
MAY CAUSE ANGINA PECTORIS & MAY BE FATAL. ETHYL ALCOHOL: EYE, NOSE,
THROAT, MUCOUS MEMBRANE & RESPIRATORY IRRITATION. PROPYLENE GLYCOL:
MODERATE SKIN IRRITANT. (SE E SUPPLEMENTAL INFORMATION)
Explanation of Carcinogenicity:NONE
Effects of Overexposure:NITROGLYCERIN: SEVERE HEADACHE. ADVERSE
REACTIONS TO THERAPEUTIC USE: TACHYCARDIA, NAUSEA, VOMITING,
APPREHENSION, MUSCLE TWITCHING, PALPITATIONS & ABDOMINAL PAIN.
ETHYL ALCOHOL: HEADACHE, DROWSINESS, LASSITUDE, LOSS OF APPETITE,
INABILITYTO CONCENTRATE, STUPOR, FATIGUE & SLEEPINESS.

First Aid

First Aid:EYES: FLUSH W/WATER FOR 15 MINS. SKIN: WASH W/SOAP & WATER.
INHALATION: REMOVE TO FRESH AIR. INGESTION: SEEK PROMPT MEDICAL
ATTENTION. ACCIDENTAL INJECTION: SEEK PROMPT MEDICAL ATTENTION.
OBTAIN MEDIC AL ATTENTION IN ALL CASES.

Fire Fighting

Extinguishing Media:CO2, DRY CHEMICAL, FOAM, WATER SPRAY
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:FLAMMABLE LIQUIDS.

Accidental Release

Spill Release Procedures:WEAR PROTECTIVE EQUIPMENT, ESPECIALLY WHEN
CLEANING UP SPILLS WHICH INVOLVE BROKEN GLASS OR DROPPED SYRINGES.
COLLECT MATERIAL. WASH ALL CONTAMINATED SURFACES W/SOAP & WATER.
PLACE WASTE IN APPROPRIAT ELY LABELED, SEALED CONTAINER FOR FUTURE
DISPOSAL.

Handling

Other Precautions:MATERIAL SHOULD BE HANDLED IN SUCH A WAY AS TO AVOID
SKIN & EYE CONTACT.

Exposure Controls

Ventilation:EXERCISE CAUTION WHEN PURGING AIR FROM THE ADMINISTRATION
SYSTEM.
Protective Gloves:REQUIRED
Eye Protection:REQUIRED
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE. WASH EXPOSED SKIN PROMPTLY.
Supplemental Safety and Health
HEALTH HAZARD INFORMATION PERTAINS TO THE INGREDIENTS INDIVIDUALLY &
NOT TO THE PRODUCT AS MARKETED.

Chemical Properties

Spec Gravity:0.977
Appearance and Odor:CLEAR LIQUID, PRACTICALLY COLORLESS SOLUTION

Stability

Stability Indicator/Materials to Avoid:YES
Stability Condition to Avoid:HEAT & IGNITION SOURCES
Hazardous Decomposition Products:OXIDES OF CARBON & NITROGEN

Disposal

Waste Disposal Methods:DISPOSE OF AS MEDICAL WASTE IN ACCORDANCE
W/FEDERAL, STATE & LOCAL REGULATIONS. INCINERATION IN A PERMITTED
INCINERATOR IS PREFERRED.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.